Table 1 Main characteristics of the analyzed studies
Study | Design | Total N of Patients | Follow-Up Time | Exclusion Criteria | HF Patients’ Age (years) | No HF Patients’ Age (years) | Male Sex HF No HF | HF Definition | |
|---|---|---|---|---|---|---|---|---|---|
Hasin et al., 2013 [8] | Case-control and prospective cohort study | 1.922 (961/961) case-control; 1.192 (596/596) cohort. | 7.7 ± 6.4 years | Prior cancer | 73,0 ± 14,0 | 73,0 ± 14,0 | 47% | 47% | Medical chart review (Framingham criteria) |
Banke et al., 2016 [9] | Cohort study | 4.968,582 (9304/4.959.275) | 4.5 ± 2.3 years | Prior cancer | 51,6 ± 7,1 | N.A. | 72.6% | Clinical evaluation and echocardiography | |
Hasin et al., 2016 [10] | Prospective cohort study | 1.081 (228/853) | 4.9 ± 3 years | Prior cancer, nonmelanoma skin cancer | 62,0 ± 15,0 | 72,0 ± 14,0 | 46% | 63% | Medical chart review (Framingham criteria) |
Selvaraj et al., 2018 [11] | Prospective cohort study (post-hoc analysis of RCT) | 28.341 (1.420/26.921) | 19.9 years | Prior cancer | 61,0 ± 9,0 | 55,0 ± 1,0 | 100% | Self report validated by Framingham criteria | |
Schwartz et al., 2020 [12] | Retrospective cohort Study | 1.004.759 (167.633/837.126) | Mean 3.0 years for HF group/6.8 yeas for control group | Prior cancer | 70,9 ± 13,3 | 70,9 ± 13,3 | 55% | 55% | ICD-10 codes |
Kwak et al., 2020 [13] | Retrospective cohort study | 770.646 (128.441/642.205) | 4.06 years | Prior cancer | 67,1 ± 12,4 | 67,1 ± 12,4 | 51.9% | 51.9% | ICD-10 code with at least one hospital admission attributed to HF diagnosis |
Roderburg et al., 2021 [14] | Retrospective cohort study | 200.248 (100.124/100.124) | 10 years | Prior cancer | 72,6 ± 12,2 | 72,6 ± 12,2 | 46% | 46% | ICD-10 code and drug prescriptions |
Leedy et al., 2021 [15] | Post-hoc analysis of a prospective cohort study | 146.817 (3.272/104.020) | 8.4 years | Prior cancer, no follow-up data, self-reported HF | 63,1 ± 6,7 | N.A. | None | Clinical review of hospitalization records with primary diagnosis of HF event | |
Bertero et al., 2021 [16] | Retrospective cohort study | 208.040 (104.020/104.020) | Mean 5.6 years for HF group/5.3 years for controls | Prior cancer; age < 50 years | 76,0 ± 10,0 | 76,0 ± 10,0 | 46.8% | 46.8% | Health Care records on drug prescriptions, outpatients visit reports, health care cost-related fee waivers, death certificates. |